Anti‐atherosclerotic effects of vitamin E – myth or reality?
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Atherosclerosis and its complications such as coronary heart disease, myocardial infarction and stroke are the leading causes of death in the developed world. High blood pressure, diabetes, smoking and a diet high in cholesterol and lipids clearly increase the likelihood of premature atherosclerosis, albeit other factors, such as the individual genetic makeup, may play an additional role. Several epidemiological studies and intervention trials have been performed with vitamin E, and some of them showed that it prevents atherosclerosis. For a long time, vitamin E was assumed to act by decreasing the oxidation of LDL, a key step in atherosclerosis initiation. However, at the cellular level, vitamin E acts by inhibition of smooth muscle cell proliferation, platelet aggregation, monocyte adhesion, oxLDL uptake and cytokine production, all reactions implied in the progression of atherosclerosis. Recent research revealed that these effects are not the result of the antioxidant activity of vitamin E, but rather of precise molecular actions of this compound. It is assumed that specific interactions of vitamin E with enzymes and proteins are at the basis of its non‐antioxidant effects. Vitamin E influences the activity of several enzymes (e.g.PKC, PP2A, COX‐2, 5‐lipooxygenase, nitric oxide synthase, NADPH oxidase, superoxide dismutase, phopholipase A2) and modulates the expression of genes that are involved in atherosclerosis (e.g.scavenger receptors, integrins, selectins, cytokines, cyclins). These interactions promise to reveal the biological properties of vitamin E and allow designing better strategies for the protection against atherosclerosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention
Jiang, Q., Christen, S., Shigenaga, M. K., & Ames, B. N. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.714 · Cited by 776 · cited 2×
“-CEHC has natriuretic properties [27] and inhibits the cyclooxygenase-2 (COX-2) in macrophages, which thus leads to the diminution of prostaglandin synthesis [28, 29].”
BackgroundNF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 1×
“A series of genes known to be involved in atherosclerosis development are regulated by NF- B, such as the genes of tumour necrosis factor , interleukin 1, macrophages or granulocyte colonies stimulating factor, monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), and intracellular adhesi…”
BackgroundMartin, G., Schoonjans, K., Lefebvre, A.-M., Staels, B., & Auwerx, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28210 · Cited by 551
Devaraj, S., Li, D., & Jialal, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118848 · Cited by 333
Salonen, J. T., Nyyssönen, K., Salonen, R., Lakka, H. ‐., Kaikkonen, J., Porkkala‐Sarataho, E., Voutilainen, S., Lakka, T. A., Rissanen, T., Leskinen, L., et al. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00752.x · Cited by 327 · cited 1×
“The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study [38] investigated the effect of RRR-tocopheryl-acetate, vitamin C, a combination of both or placebo on the progression in intima-tomedia thickness (IMT) of common carotid artery, used as a marker of on-going atherosclerotic disease.”
MethodZapolska-Downar, D., Zapolski-Downar, A., Markiewski, M., Ciechanowicz, A., Kaczmarczyk, M., & Naruszewicz, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3197 · Cited by 54
Cited by
Cook-Mills, J. M., Marchese, M. E., & Abdala-Valencia, H. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3522 · Cited by 594
Ageing, age-related diseases and oxidative stress: What to do next?
Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581
“tocopherol levels could only increase less than 2-3 times no matter the amount or duration of supplementation (Munteanu et al., 2004).”
BackgroundVITAMIN E, OXIDATIVE STRESS, AND INFLAMMATION
Singh, U., Devaraj, S., & Jialal, I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132446 · Cited by 575
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Chemistry and biology of vitamin E
Schneider, C. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400049 · Cited by 542
Metadata
- Authors
- Munteanu, A., Zingg, J. ‐., & Azzi, A.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 8
- Issue
- 1
- Pages
- 59-76
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2037726433
- Cited by
- 145
- References
- 10
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐atherosclerotic effects of vitamin E – myth or reality? https://app.cochat.ai/papers/10.1111/j.1582-4934.2004.tb00260.x
- The paper
- Munteanu, A., Zingg, J. ‐., & Azzi, A. (2004). Anti‐atherosclerotic effects of vitamin E – myth or reality? Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2004.tb00260.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.